RIPK1 and melanoma: Several previous studied in gallbladder carcinoma, melanoma, breast cancer, HCC, and CCA suggested that RIPK1 harbors pro-tumorigenic functions through different mechanisms including NF-κB, autophagy, and apoptosis activation [53, 80–85].